Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM50347097 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_752994 (CHEMBL1798818) | ||
IC50 | 30±n/a nM | ||
Citation | Selness, SR; Boehm, TL; Walker, JK; Devadas, B; Durley, RC; Kurumbail, R; Shieh, H; Xing, L; Hepperle, M; Rucker, PV; Jerome, KD; Benson, AG; Marrufo, LD; Madsen, HM; Hitchcock, J; Owen, TJ; Christie, L; Promo, MA; Hickory, BS; Alvira, E; Naing, W; Blevis-Bal, R; Devraj, RV; Messing, D; Schindler, JF; Hirsch, J; Saabye, M; Bonar, S; Webb, E; Anderson, G; Monahan, JB Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase. Bioorg Med Chem Lett21:4059-65 (2011) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM50347097 | |||
n/a | |||
Name | BDBM50347097 | ||
Synonyms: | CHEMBL1797125 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H14BrCl2NO2 | ||
Mol. Mass. | 439.13 | ||
SMILES | Cc1cc(OCc2ccccc2)c(Br)c(=O)n1-c1c(Cl)cccc1Cl |(2.07,-8.4,;.74,-9.16,;-.59,-8.39,;-1.92,-9.16,;-3.26,-8.4,;-4.59,-9.17,;-5.92,-8.4,;-5.92,-6.87,;-7.26,-6.1,;-8.59,-6.87,;-8.58,-8.42,;-7.24,-9.18,;-1.92,-10.7,;-3.25,-11.48,;-.59,-11.47,;-.59,-13.01,;.74,-10.7,;2.07,-11.48,;3.39,-10.71,;3.39,-9.17,;4.73,-11.47,;4.73,-13.02,;3.39,-13.79,;2.06,-13.02,;.73,-13.78,)| | ||
Structure |